A sugar drug that proves successful in treating heart failure … An American study reveals

American researchers said that empagliflozin, a drug recently developed for diabetes, can effectively treat heart failure in diabetics and non-diabetics, as the clinical trial, published in the Journal of the American College of Cardiology, showed that this drug can improve the size and shape of the heart. And its function, which leads to improved exercise capacity and quality of life, which reduces hospitalization for heart failure patients.

According to a newspaper report TIME NOW NEWS The study author said Carlos Santos “The promising results from our clinical trials show that this diabetes drug can improve the lives of patients with heart failure with reduced ejection fraction, enhance their ability to exercise, and improve their quality of life with little or no side effects. ”

Santos Gallego added: “Our study also identifies why this drug is so effective: because it improves heart function, which is not yet understood.”“.

Importantly, the researchers note that the drug does not appear to cause hypoglycemia, or low blood sugar, in patients without diabetes..

For the sake of the experiment, known as “EMPATROPISM” , Researchers recruited 84 patients with chronic heart failure with reduced ejection fraction (EF) Percentage of left ventricular pumps in blood with each contraction and subjected to treatment with empagliflozin or placebo .

They all underwent basic evaluations including a cardiac MRI, a cardiopulmonary exercise test on a bicycle wearing a face mask to text oxygen levels, a six-minute walking test, and quality of life questionnaires, patients received treatment or placebo for six months, with some short safety visits At one and three months at the six-month mark, the patients underwent the same tests.

Researchers found that approximately 80% of patients treated with empagliflozin showed significant improvement, and their hearts had nearly returned to normal..

Their hearts became smaller and less dilated due to less congestion and fluid accumulation in the body, which means that their heart failure became less severe and the walls of the heart thinner, the study also showed that patients taking empagliflozin had about 10% improvement in their levels of exercise, which is an important difference from Statistically.

– .